- About
-
Projects
-
Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
-
Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
-
Column 1
- News and Events
- Expanded Access eRequest
Announcements
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
(February 6, 2026) The Reagan-Udall Foundation for the FDA (Foundation) has appointed Adrian F. Hernandez, MD, MHS, as Chair of its Board of Directors. Dr. Hernandez, who has served on the Board since 2019, is a cardiologist and the Vice Dean for…
The Reagan-Udall Foundation for the FDA will honor the Produce Safety Alliance, Critical Path Institute, and Loren A. Eng with its Innovations in Regulatory Science & Policy Awards on December 9, 2025.
Coverage
The Reagan-Udall Foundation for the FDA just released a new report on strengthening early-stage drug development in the United States.
On May 27, 2026, the Reagan-Udall Foundation for the FDA, working alongside ARPA-H and the XPRIZE Foundation, ran a full-day public meeting on gerotherapeutic drug and biologic development.
Researchers from the University of California San Diego have found that U.S. overdose death rates declined dramatically between 2023 and 2024, marking the first recorded drop in all four waves of the nation’s overdose crisis.